Stockscreener 앱 받기
6.99
9.73%
0.62
시간 외 거래:
7.00
0.010
+0.14%
전일 마감가:
$6.37
열려 있는:
$6.27
하루 거래량:
103.41K
Relative Volume:
1.57
시가총액:
$204.09M
수익:
$65.42M
순이익/손실:
$-32.96M
주가수익비율:
-4.1118
EPS:
-1.7
순현금흐름:
$-19.87M
1주 성능:
+7.70%
1개월 성능:
+2.34%
6개월 성능:
-48.75%
1년 성능:
-2.51%
1일 변동 폭
$6.27
$7.15
1주일 범위
$6.03
$7.15
52주 변동 폭
$5.45
$18.15
뉴로페이스 Stock (NPCE) Company Profile
명칭
Neuropace Inc
전화
(650) 237-2700
주소
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
뉴로페이스 Stock (NPCE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-24 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-02-22 | 개시 | Lake Street | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-18 | 개시 | Robert W. Baird | Outperform |
| 2021-05-17 | 개시 | JP Morgan | Overweight |
| 2021-05-17 | 개시 | Morgan Stanley | Overweight |
| 2021-05-17 | 개시 | SVB Leerink | Outperform |
| 2021-05-17 | 개시 | Wells Fargo | Overweight |
모두보기
뉴로페이스 주식(NPCE)의 최신 뉴스
NeuroPace (NPCE) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy - ForexTV.com
NeuroPace submits RNS System study data to FDA - Investing.com
How to Take Advantage of moves in (NPCE) - Stock Traders Daily
Analysts Set NeuroPace, Inc. (NASDAQ:NPCE) Target Price at $14.00 - Defense World
NeuroPace, Inc. (NASDAQ:NPCE) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength? - MSN
Deep Brain Stimulation Devices Market Growing Popularity & Emerging Trends | Medtronic, NeuroPace, LivaNova - openPR
KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares - Yahoo Finance
Neuropace shareholder KCK Ltd. sells $1.22 million in stock By Investing.com - Investing.com South Africa
Neuropace shareholder KCK Ltd. sells $1.22 million in stock - Investing.com
Ltd. Kck Sells 223,991 Shares of NeuroPace, Inc. (NASDAQ:NPCE) Stock - MarketBeat
KCK LTD. Adjusts Stake in NeuroPace Inc - GuruFocus.com
Neuropace Inc sees $24,853 stock sale by major shareholder - Investing.com
Page 85 – Impact Investing - Equities News
Neuropace stock hits 52-week low at $5.66 amid market challenges - Investing.com Australia
NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024 - The Manila Times
Neuropace sees $53,370 in stock sales by major shareholder - Investing.com
NeuroPace, Inc. (NASDAQ:NPCE) Major Shareholder Ltd. Kck Sells 3,720 Shares - MarketBeat
Neuropace Inc: KCK Ltd. sells $303,366 in shares By Investing.com - Investing.com South Africa
Neuropace Inc: KCK Ltd. sells $303,366 in shares - Investing.com India
KCK LTD. Reduces Stake in NeuroPace Inc - GuruFocus.com
Insider Selling: NeuroPace, Inc. (NASDAQ:NPCE) Major Shareholder Sells 2,572 Shares of Stock - MarketBeat
NeuroPace Continues to Strengthen Management Team - The Manila Times
NeuroPace appoints new VP of Human Resources - Investing.com
NeuroPace appoints new VP of Human Resources By Investing.com - Investing.com UK
Marshall Wace LLP Sells 26,313 Shares of NeuroPace, Inc. (NASDAQ:NPCE) - Defense World
Millennium Management LLC Acquires 80,324 Shares of NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat
Augmented Humanity Technologies Industry to Witness Growth Acceleration by (2024-2034) - IndiaPolitics.com
Brain Computer Interface (BCI) Industry – Key Innovations and Future Market Scope - TIMC
Neurostimulation Devices Market is Estimated to Reach $11.26 Billion By 2032 - 대구포스트
Implantable Pulse Generator Market Report 2024: Size, Share, Growth, Forecast to 2033 - WhaTech
Neuroscience Industry Report By Type, Application and Geography - Elektrotransports.lv
Digital Health Monitoring Devices Industry Business Development, Trends - Elektrotransports.lv
Cubist Systematic Strategies LLC Decreases Stock Holdings in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World
Matthias Stangl Receives R00 Grant from NIH - Boston University
Brokerages Set NeuroPace, Inc. (NASDAQ:NPCE) Target Price at $14.00 - MarketBeat
Down Over 60% In 3 Months, Will NeuroPace Stock Regain Its Pace? - RTTNews
Trading (NPCE) With Integrated Risk Controls - Stock Traders Daily
Nantahala Capital Management LLC Reduces Holdings in NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat
XTX Topco Ltd Increases Stock Position in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World
Rhumbline Advisers Takes $111,000 Position in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World
NeuroPace's SWOT analysis: epilepsy device maker's stock poised for growth By Investing.com - Investing.com Australia
NeuroPace (NPCE) Q2 Earnings Beat, '24 Sales View Up - MSN
34,059 Shares in NeuroPace, Inc. (NASDAQ:NPCE) Acquired by Bank of New York Mellon Corp - Defense World
BCI and EEG Market Future Developments, Upcoming Trends, and Top-Vendor Landscape 2020 to 2032 Medtronic, Natus Medical, Nihon Kohden, NeuroPace Inc – Cauverynews - Cauverynews
National Bank of Canada (OTCMKTS:NTIOF) Hits New 1-Year High at $94.20 - Defense World
Understanding the Risks of Investing in Noble Corp Plc (NE) - Knox Daily
Nothing is Better Than New Found Gold Corp (NFGC) stock at the moment - SETE News
Internal Neuromodulation Devices Market Size, Trends And Forecast 2024-2033 - WhaTech
뉴로페이스 (NPCE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
뉴로페이스 주식 (NPCE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| KCK LTD. | 10% Owner |
Oct 23 '24 |
Sale |
6.02 |
147 |
885 |
5,494,836 |
0.47%
1.00%
자본화:
|
볼륨(24시간):